scholarly journals Dynamic Regulation of K and Ca Currents in Lipotoxic Supraventricular Arrhythmias

2020 ◽  
Vol 118 (3) ◽  
pp. 345a
Author(s):  
Laura Martinez-Mateu Martinez-Mateu ◽  
Charles Leduc ◽  
Xusheng Zhang ◽  
Lisa Cole Burnett ◽  
Xiaoyun Sun ◽  
...  
2012 ◽  
Vol 34 (3) ◽  
pp. 296-306
Author(s):  
Kai-Fa WEI ◽  
Juan CHEN ◽  
Yan-Feng CHEN ◽  
Ling-Juan WU ◽  
Wen-Suo JIA

2021 ◽  
Vol 99 (4) ◽  
pp. 531-553 ◽  
Author(s):  
Cindrilla Chumduri ◽  
Margherita Y. Turco

AbstractHealthy functioning of the female reproductive tract (FRT) depends on balanced and dynamic regulation by hormones during the menstrual cycle, pregnancy and childbirth. The mucosal epithelial lining of different regions of the FRT—ovaries, fallopian tubes, uterus, cervix and vagina—facilitates the selective transport of gametes and successful transfer of the zygote to the uterus where it implants and pregnancy takes place. It also prevents pathogen entry. Recent developments in three-dimensional (3D) organoid systems from the FRT now provide crucial experimental models that recapitulate the cellular heterogeneity and physiological, anatomical and functional properties of the organ in vitro. In this review, we summarise the state of the art on organoids generated from different regions of the FRT. We discuss the potential applications of these powerful in vitro models to study normal physiology, fertility, infections, diseases, drug discovery and personalised medicine.


2021 ◽  
Vol 10 (7) ◽  
pp. 1456
Author(s):  
Carlo Lavalle ◽  
Michele Magnocavallo ◽  
Martina Straito ◽  
Luca Santini ◽  
Giovanni Battista Forleo ◽  
...  

Transcatheter ablation was increasingly and successfully used to treat symptomatic drug refractory patients affected by supraventricular arrhythmias. Antiarrhythmic drug treatment still plays a major role in patient management, alone or combined with non-pharmacological therapies. Flecainide is an IC antiarrhythmic drug approved in 1984 from the Food and Drug Administration for the suppression of sustained ventricular tachycardia and later for acute cardioversion of atrial fibrillation and for sinus rhythm maintenance. Currently, flecainide is mostly used for sinus rhythm maintenance in atrial fibrillation (AF) patients without structural cardiomyopathy although recent studies enrolling different patient populations have demonstrated a good effectiveness and safety profile. How should we interpret the results of the CAST after the latest evidence? Is it possible to expand the indications of flecainide, and therefore, its use? This review aims to highlight the main characteristics of flecainide, as well as its optimal clinical use, delineating drug indications and contraindications and appropriate monitoring, based on the most recent evidence.


2020 ◽  
Vol 88 ◽  
pp. S75
Author(s):  
Constandina Pospori ◽  
William Grey ◽  
Shayin Gibson ◽  
Sara Gonzalez-Anton ◽  
Thomas Williams ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document